Literature DB >> 22928765

Substrate-assisted catalytic mechanism of O-GlcNAc transferase discovered by quantum mechanics/molecular mechanics investigation.

Igor Tvaroška1, Stanislav Kozmon, Michaela Wimmerová, Jaroslav Koča.   

Abstract

In higher eukaryotes, a variety of proteins are post-translationally modified by adding O-linked N-acetylglucosamine (GlcNAc) residue to serine or threonine residues. Misregulation of O-GlcNAcylation is linked to a wide variety of diseases, such as diabetes, cancer, and neurodegenerative diseases, including Alzheimer's disease. GlcNAc transfer is catalyzed by an inverting glycosyltransferase O-GlcNAc transferase (uridine diphospho-N-acetylglucosamine:polypeptide β-N-acetylaminyltransferase, OGT) that belongs to the GT-B superfamily. The catalytic mechanism of this metal-independent glycosyltransferase is of primary importance and is investigated here using QM(DFT)/MM methods. The structural model of the reaction site used in this paper is based on the crystal structures of OGT. The entire enzyme-substrate system was partitioned into two different subsystems: the QM subsystem containing 198 atoms, and the MM region containing 11,326 atoms. The catalytic mechanism was monitored by means of three two-dimensional potential energy maps calculated as a function of three predefined reaction coordinates at different levels of theory. These potential energy surfaces revealed the existence of a concerted S(N)2-like mechanism, in which a nucleophilic attack by O(Ser), facilitated by proton transfer to the catalytic base, and the dissociation of the leaving group occur almost simultaneously. The transition state for the proposed reaction mechanism at the MPW1K level was located at C1-O(Ser) = 1.92 Å and C1-O1 = 3.11 Å. The activation energy for this passage was estimated to be ~20 kcal mol(-1). These calculations also identified, for the first time for glycosyltransferases, the substrate-assisted mechanism in which the N-acetamino group of the donor participates in the catalytic mechanism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22928765     DOI: 10.1021/ja307040m

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  7 in total

Review 1.  The making of a sweet modification: structure and function of O-GlcNAc transferase.

Authors:  John Janetzko; Suzanne Walker
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

2.  Glycobiology: The case of the missing base.

Authors:  Stephen G Withers; Gideon J Davies
Journal:  Nat Chem Biol       Date:  2012-10-28       Impact factor: 15.040

Review 3.  O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.

Authors:  John A Hanover; Weiping Chen; Michelle R Bond
Journal:  J Bioenerg Biomembr       Date:  2018-03-29       Impact factor: 2.945

4.  The active site of O-GlcNAc transferase imposes constraints on substrate sequence.

Authors:  Shalini Pathak; Jana Alonso; Marianne Schimpl; Karim Rafie; David E Blair; Vladimir S Borodkin; Osama Albarbarawi; Daan M F van Aalten
Journal:  Nat Struct Mol Biol       Date:  2015-08-03       Impact factor: 15.369

5.  Structural, mutagenic and in silico studies of xyloglucan fucosylation in Arabidopsis thaliana suggest a water-mediated mechanism.

Authors:  Breeanna R Urbanowicz; Vivek S Bharadwaj; Markus Alahuhta; Maria J Peña; Vladimir V Lunin; Yannick J Bomble; Shuo Wang; Jeong-Yeh Yang; Sami T Tuomivaara; Michael E Himmel; Kelley W Moremen; William S York; Michael F Crowley
Journal:  Plant J       Date:  2017-08-28       Impact factor: 6.417

6.  A computational and experimental study of O-glycosylation. Catalysis by human UDP-GalNAc polypeptide:GalNAc transferase-T2.

Authors:  Hansel Gómez; Raúl Rojas; Divya Patel; Lawrence A Tabak; José M Lluch; Laura Masgrau
Journal:  Org Biomol Chem       Date:  2014-05-07       Impact factor: 3.876

7.  Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma.

Authors:  Negar Babae; Meriem Bourajjaj; Yijia Liu; Judy R Van Beijnum; Francesco Cerisoli; Puthupparampil V Scaria; Mark Verheul; Maaike P Van Berkel; Ebel H E Pieters; Rick J Van Haastert; Afrouz Yousefi; Enrico Mastrobattista; Gert Storm; Eugene Berezikov; Edwin Cuppen; Martin Woodle; Roel Q J Schaapveld; Gregoire P Prevost; Arjan W Griffioen; Paula I Van Noort; Raymond M Schiffelers
Journal:  Oncotarget       Date:  2014-08-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.